BTIG Maintains Buy on Verastem, Lowers Price Target to $18

Benzinga Newsdesk www.benzinga.com Negative 75.1%

Neg 75.1% Neu 0% Pos 0%

BTIG analyst Jeet Mukherjee maintains Verastem (NASDAQ:VSTM) with a Buy and lowers the price target from $19 to $18.

Comments

No comments yet. Be the first!